Sinopharm Group Co. Ltd. (SHTDY)
OTC: SHTDY
· Real-Time Price · USD
12.51
0.19 (1.50%)
At close: Aug 15, 2025, 3:55 PM
12.48
-0.27%
After-hours: Aug 15, 2025, 03:17 PM EDT
Sinopharm Cash Flow Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 2.28B | 1.42B | 2.96B | 1.99B | 2.51B | 1.59B | 2.67B | 2.16B | 2.27B | 1.43B | 2.06B | 2.12B | 2.37B | 1.22B |
Depreciation & Amortization | 2.33B | n/a | 4.24B | -2.1B | 2.1B | n/a | 4B | -2B | 2B | n/a | 3.78B | -1.88B | 1.88B | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 5.46B | n/a | 3.71B | -5.74B | 5.74B | n/a | -5.91B | 3.31B | -3.31B | n/a | 421.26M | 610.45M | -610.45M | n/a |
Other Non-Cash Items | 63.24B | -48.9B | 60.33B | -68.13B | 64.65B | -42.28B | 60.42B | -46.27B | 46.9B | -37.92B | 64.74B | -52.92B | 52.65B | -36.06B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -61.37B | n/a | -10.69B | 71.89B | -71.89B | n/a | -14.7B | 48.97B | -48.97B | n/a | -30.64B | 49.83B | -49.83B | n/a |
Operating Cash Flow | 6.49B | -47.48B | 56.84B | 3.66B | -2.63B | -40.69B | 52.39B | 2.87B | 2.2B | -36.49B | 39.94B | -2.86B | 7.07B | -34.84B |
Capital Expenditures | -550.03M | -473.1M | -983.87M | -495.13M | -312.96M | -406.41M | -945.08M | -549.75M | -442.19M | -427.89M | -722.79M | -559.15M | -417.32M | -374.65M |
Cash Acquisitions | -4.97M | -97.04M | 42.54M | -82.12M | 221K | -26.14M | -233.31M | 54.06M | -163.07M | n/a | -288.96M | 25.04M | -44.44M | -188.86M |
Purchase of Investments | n/a | n/a | 61.51M | 222.34M | n/a | n/a | 78.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | -150.49M | 110.03M | n/a | n/a | -63.84M | 137.02M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -739.63M | 826.26M | -875.99M | -922.75M | 1.08B | 848.56M | -1.41B | -705.59M | 913.41M | 510.76M | -390.62M | 581.22M | 167.9M | 945.66M |
Investing Cash Flow | -1.29B | 256.12M | -957.39M | -1.17B | 764.46M | 416.01M | -2.57B | -1.41B | 308.16M | 82.87M | -1.4B | 47.1M | -293.85M | 382.15M |
Debt Repayment | 8.3B | 15.57B | -25.18B | 2.81B | 8.19B | 15.66B | -17.43B | -4.69B | 10.15B | 14.89B | -18.21B | -3.05B | 4.76B | 9.95B |
Common Stock Repurchased | -59.88M | n/a | n/a | n/a | -13.9M | n/a | n/a | n/a | -64.63M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | -1.11B | -2.78B | -5.33B | n/a | -1.17B | -2.8B | -5.14B | n/a | -1.02B | -2.37B | -4.53B | n/a | -777.28M |
Other Financial Acitivies | -8.85B | 7.7B | -151.15M | -1.09B | -7.99B | 6.63B | -5.98B | -111.99M | -7.29B | 5.86B | -4B | 857.37M | -6.24B | 4.16B |
Financial Cash Flow | -602.7M | 22.15B | -25.33B | -3.61B | 185.36M | 21.11B | -23.41B | -4.8B | 2.79B | 19.72B | -19.84B | -6.72B | -1.48B | 13.34B |
Net Cash Flow | 4.59B | -25.07B | 30.55B | -1.12B | -2.15B | -18.69B | 26.39B | -3.32B | 5.21B | -16.59B | 18.7B | -9.53B | 5.2B | -21.02B |
Free Cash Flow | 5.94B | -47.95B | 55.86B | 3.16B | -2.95B | -41.1B | 51.45B | 2.32B | 1.76B | -36.92B | 39.21B | -3.42B | 6.66B | -35.22B |